Abstract
Migraine is a widespread and impairing nervous disorder that affects millions of people worldwide (Wang et al., 2023). The existing treatment programs often fail to be effective due to the partial nature of symptom management and numerous side effects, which leads most patients to consider alternative or complementary treatments (Puledda et al., 2023). The white paper is an assessment of a patented migraine headache treatment modality that uses six proprietary blends, mainly natural compounds. The method involves a graded, systematic dose schedule over a defined treatment period. This review aims to evaluate the prospects of this patented intervention to propel migraine management in health facilities. The formulated analysis focuses on clinical relevance, mechanistic justification, and the implications of integrative and personalized medicine. Even though large-scale clinical validation has yet to be conducted, the patented approach offers an appealing framework for discussing the multifactorial etiology of migraines. It aligns with the emerging trend of delivering healthcare holistically and through a systems approach.
References
- Biagioli V., et al. “The Interplay Between Gut Microbiota, Adipose Tissue, and Migraine: A Narrative Review”. Nutrients 17.2 (2025): 337-337.
- Domitrz I and Cegielska J. “Magnesium as an Important Factor in the Pathogenesis and Treatment of Migraine from Theory to Practice”. Nutrients 14.5 (2022): 1089.
- Eigenbrodt AK, Ashina H and Khan S. “Diagnosis and management of migraine in ten steps”. Nature Reviews Neurology 17.8 (2021): 1-14.
- Grodzka O and Domitrz I. “Gut microbiota, probiotics, and migraine: a clinical review and meta-analysis”. Journal of Oral & Facial Pain and Headache (2025).
- Haghdoost F and Togha M. “Migraine management: Non-pharmacological points for patients and health care professionals”. Open Medicine 17.1 (2022); 1869-1882.
- Hajhashemy Z., et al. “Practical supplements for prevention and management of migraine attacks: a narrative review”. Frontiers in Nutrition 11 (2024).
- Khan J., et al. “Genetics, pathophysiology, diagnosis, treatment, management, and prevention of migraine”. Biomedicine & Pharmacotherapy 139 (2021): 111557.
- Lampl C., et al. “The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis”. The Journal of Headache and Pain 24.1 (2023).
- Olesen J. “The International Classification of Headache Disorders: History and future perspectives”. Cephalalgia 44.1 (2024).
- Puledda F., et al. “Migraine: from pathophysiology to treatment”. Journal of Neurology 270 (2023).
- Ruschel MAP and De Jesus O. “Migraine Headache”. StatPearls Publishing (2024).
- Savran OY and Tuncer M. “Possible Role of Novel Mitochondrial Subsets in Migraine”. Life 15.8 (2025): 1273.
- Sharma J, Soni R and Singh S. “Recent Trends in the Pharmacological Treatment of Chronic Migraine: A Systematic Review of Randomized Controlled Trials”. Cureus (2025).
- Wang Z., et al. “Primary headache disorders: From pathophysiology to neurostimulation therapies”. Heliyon 9.4 (2023): e14786-e14786.
- Yamanaka G., et al. “Experimental and Clinical Evidence of the Effectiveness of Riboflavin on Migraines”. Nutrients 13.8 (2021): 2612.